17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study

Lindsay J. Collin*, Sinna P. Ulrichsen, Thomas P. Ahern, Michael Goodman, Lauren E. McCullough, Lance A. Waller, Kristina Bang Christensen, Per Damkier, Stephen Hamilton-Dutoit, Kristina L. Lauridsen, Rami Yacoub, Peer M. Christiansen, Bent Ejlertsen, Henrik Toft Sørensen, Deirdre P. Cronin-Fenton, Timothy L. Lash

*Corresponding author for this work

Research output: Contribution to journalLetterResearchpeer-review

Original languageEnglish
JournalActa Oncologica
Volume59
Issue number3
Pages (from-to)329-333
ISSN0284-186X
DOIs
Publication statusPublished - Mar 2020

Cite this

Collin, L. J., Ulrichsen, S. P., Ahern, T. P., Goodman, M., McCullough, L. E., Waller, L. A., Bang Christensen, K., Damkier, P., Hamilton-Dutoit, S., Lauridsen, K. L., Yacoub, R., Christiansen, P. M., Ejlertsen, B., Sørensen, H. T., Cronin-Fenton, D. P., & Lash, T. L. (2020). 17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study. Acta Oncologica, 59(3), 329-333. https://doi.org/10.1080/0284186X.2019.1684560